Pantoprazole Sodium
| Grade | Pharmaceutical |
| Pharmacopoeia | BP, USP |
| CAS No. | 164579-32-2 |
| Product Name | Pantoprazole Sodium |
| Chemical Name | Sodium 5-(difluoromethoxy)-2-[(RS)-[(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl]benzimidazol-1-ide sesquihydrate |
| Function | Active Pharmaceutical Ingredients (APIs) |
| Industrial Application | Pharmaceutical |
| Category | Proton pump inhibitor |
General Description
Pantoprazole is a proton pump inhibitor used to reduce the amount of acid produced in the stomach. It helps treat conditions like gastroesophageal reflux disease (GERD), heartburn, acid reflux, and Zollinger-Ellison syndrome. It is effective in allowing the esophagus to heal and preventing further acid-related damage in adults.
Physical Characteristics
| Molecular formula | C₁₆H₁₄F₂N₃NaO₄S · 1.5 H₂O |
| Molecular weight | 432.37 |
| Appearance | White or almost white powder |
| Solubility | Freely soluble in water and ethanol (96%), practically insoluble in hexane |
| Water | 5.9% to 6.9% |
| Optical rotation | -0.4° to +0.4° |
| Purity | Minimum 99.5% |
| Assay | 99.0% to 101.0% (anhydrous substance) |
| Storage | Protected from light |
| Stability | Stable at least 2 years at room temperature |